|
|
Other links at Articles > Gastroenterology |
| 1. |
Telbivudine Better Than Lamivudine for Chronic Hepatitis B
|
|
|
As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and -negative patients, according to 2-year follow-up data from the GLOBE trial. Reuters Health Information
|
| 2. |
Gut Colonization With Oxalobacter Formigenes May Cut Risk of Kidney Stones
|
|
|
Intestinal colonization with Oxalobacter formigenes, a Gram-negative, anaerobic microbe common in normal adults, appears to reduce the risk of recurrent calcium oxalate stones by 70%, US investigators report. With further research, they suggest, this bacterium might one day be used as a probiotic to prevent stone formation. Reuters Health Information
|
| 5. |
The Ethics of Phase I Trials of Biologic Agents
|
|
|
Early and limited exposure to biologics can cause antibodies to develop and, ultimately, prevent trial participants from gaining any treatment benefit. In this editorial, the author calls for the risks to be clearly stated.
Nature Clinical Practice Gastroenterology & Hepatology
|
|
|